X0206 3 2018-08-14 0 0000821995 JUNIPER PHARMACEUTICALS INC JNP 0001596783 Catalent, Inc. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 0 0 1 0 Common Stock, par value $0.01 per share 9285239 I See footnote. Represents shares of Juniper Pharmaceuticals, Inc. ("Juniper") purchased by Catalent Pharma Solutions, Inc. ("CPS"), a wholly owned subsidiary of PTS Intermediate Holdings LLC (which in turn is a wholly owned subsidiary of Catalent, Inc. ("Catalent")), immediately following the expiration of the tender offer (the "Offer") at 12:00 midnight, New York City time, at the end of August 13, 2018, which Offer was effected in accordance with the Agreement and Plan of Merger, dated July 2, 2018 (the "Merger Agreement"), by and among CPS, Catalent, Catalent Boston, Inc., a wholly owned subsidiary of CPS ("Merger Sub"), and Juniper. On August 14, 2018, in accordance with the terms and conditions of the Merger Agreement, Merger Sub was merged (the "Merger") with and into Juniper, with Juniper continuing as the surviving corporation, and CPS became the sole owner of all of the 1,000 issued and outstanding shares of common stock of the surviving corporation remaining following the Merger. CPS is a wholly owned subsidiary of Catalent. /s/ Steven L. Fasman, Senior Vice President, General Counsel and Secretary 2018-08-15